市场调查报告书
商品编码
1126547
自动周边市场规模、份额、行业趋势分析报告:按最终用途、类型、应用(青光眼、年龄相关性黄斑变性、暗点)、区域展望和预测2022-2028Global Automated Visual Field Analyzer Market Size, Share & Industry Trends Analysis Report By End-use, By Type, By Application (Glaucoma, Age-related Macular Degeneration, Scotoma), By Regional Outlook and Forecast, 2022 - 2028 |
到 2028 年,全球自动周界市场规模预计将达到 2.278 亿美元,在预测期内以 7.0% 的复合年增长率增长。
指示患者在周边视觉中找到由周边提供的特定光刺激。不这样做可能会导致暗点或创伤。周边投射一系列不同强度(亮度)的白光刺激,穿过一个均匀照明的碗。患者看到光线时通过按下手持设备上的按钮发出信号。这评估了视网膜在视野内特定位置定位刺激的能力。
这以“分贝”为单位测量,称为视网膜敏感度 (dB)。分析仪目前采用的 SITA(瑞典交互式阈值算法)可实现有史以来最快速和准确的视野评估。将结果与年龄匹配的数据库进行比较可以揭示可能是病理性的可疑或意外视力丧失。该设备可用于疾病筛查、监测和诊断支持。可以根据目的选择各种研究方法。
COVID-19 影响分析
由于医院的选择性程序(包括眼科检查)延迟、感染风险以及就诊眼科诊所的人数等因素,COVID-19 对自动眼科设备市场产生了负面影响。正在减少。限制该行业的其他挑战包括价格压力、眼科医生短缺、竞争加剧和高成本。此外,还有临床意义,例如减少预约、避免某些疗法、使用更多设备和新的程序实践。正在鼓励人工智能和远程眼科加强医患联繫。
市场增长因素
快速的技术进步和分析仪技术的发展
在现代,自动化现场分析仪引入了许多进步。引入了一种新的软件算法,这是该仪器复杂技术的重要进步之一。产品发布频率的激增是预计推动市场扩张的主要因素之一。最近的技术发展导致了各种新的视觉功能测试的发展。
为医生和患者提供更快的周转时间
自动周界的周转时间大大缩短,视野测试的准确性与近年来相比有所提高。由于在自动周边市场上运营的几家市场参与者做出了许多努力和努力,这些分析仪的周转时间已大大缩短。更短的周转时间使一些诊所的医生能够加快患者诊断和治疗的步伐。
市场增长因素
分析仪缺乏精度和多功能性
虽然自动边界有很多优点,但它们也有很大的缺点。由于各种因素,自动周界容易出错。例如,使用自动周边完成的测试结果很容易受到不正确的头部定位的干扰。即使患者头部的轻微移动也会对测试结果产生很大影响。此外,患有严重青光眼的患者很难做出准确的诊断。
按类型划分的前景
自动外围市场按类型分为静态和动态两种。 2021 年,Kinetic 部门将在自动周边市场获得可观的收入份额。动力学边界的主要优点之一是它们能够捕捉移动刺激并产生准确的结果。它的主要优点包括增加了检查者和患者的互动、更快的外围检查和更好的空间分辨率。
应用前景
根据应用,自动周边市场细分为青光眼、年龄相关性黄斑变性 (AMD)、暗点等。 2021 年,青光眼细分市场在自动周边市场的收入份额最高。青光眼会损害眼睛的视神经,导致视力下降和失明。青光眼是由眼球内正常液体的压力稳定增加引起的。
最终用户展望
按最终用户划分,自动周边市场分为医院、眼科诊所等。 2021年,医院板块在自动周边市场的收入份额最大。该行业受到眼部相关疾病日益流行和自动化周边技术发展的推动。
区域展望
按地区分析了北美、欧洲、亚太地区和 LAMEA 的自动周边市场。 2021 年,北美占自动周边市场的最大收入份额。这是由于该地区有大量的市场参与者和眼疾患病率上升。自动周边市场是由尖端技术的高度采用和有利的报销政策推动的。
The Global Automated Visual Field Analyzer Market size is expected to reach $227.8 Million by 2028, rising at a market growth of 7.0% CAGR during the forecast period.
An automated visual field analyzer is an automated tool that is very frequently employed by Optometrists, orthoptists, and ophthalmologists to measure the human visual field, especially to identify monocular visual fields. The sort of vision defect is determined by the analyzer's results. As a result, it offers details on where any disease activates or lesion may be located along the visual pathway.
It directs and aids in the diagnosis of the visual disorder affecting the patient. These results are kept on file and utilized to keep tabs on the patient's health and the progression of vision loss. These analyzers examine the patient's whole vertical and horizontal field of peripheral vision, looking for any probable vision problems or blind spots (scotomas). Finding particular scotomas in one's vision can be a sign of a particular kind of brain injury or illness, like a tumor or stroke.
The patient is instructed to locate specific light stimuli that the analyzer has provided in their peripheral vision. If the patient is not able to do so, this may indicate scotomas or trauma. The analyzer emits a sequence of white light stimuli across a bowl that is evenly lit, with different intensities (brightness). The patient presses a button on a handheld device to signal when they see a light. This evaluates the retina's capacity to find a stimulus at particular locations within the visual field.
This is measured in 'decibels' and is known as retinal sensitivity (dB). The Swedish Interactive Thresholding Algorithm, or SITA, which is now used by the analyzer, enables the quickest and most precise visual field assessment to date. The results are then compared to an age-matched database to reveal suspicious and unexpected vision loss that may be a result of pathology. The analyzer can be employed for condition screening, monitoring, and diagnosis support. Depending on the objectives, there are a variety of testing methodologies to choose from.
COVID-19 Impact Analysis
COVID-19 had a negative impact on the automated visual field analyzers market because of elements, like the delay of elective hospital procedures, including eye exams, and the infection risk, which has led to a decline in the number of individuals attending eye clinics. Other challenges that are limiting the industry include a shortage of price pressure, ophthalmologists, escalating competition, and high costs. Additionally, it has had a clinical impact on fewer appointments, avoiding particular treatment alternatives, using more instruments, and putting new procedures into practice. Artificial intelligence and teleophthalmology are recommended for enhancing doctor-patient connections.
Market Growth Factors
Rapid Technological Advancement And Developments In The Analyzer Technology
In the modern era, there is a number of advancements that are being introduced in automated field analyzers. New software algorithms have been introduced, which is one of these significant advancements in the complex technology of this equipment. A surge in the frequency of product launches is one of the main factors projected to fuel the market's expansion. Recent developments in the technology are leading to the development of various novel visual function tests.
Offers Reduced Turnaround Time To Doctors And Patients
The turnaround time for automated visual field analyzers has greatly decreased, and accuracy in visual field testing has increased in contrast to recent years. Due to a number of efforts and initiatives being taken by several market players operating in the automated visual field analyzer market, the turnaround time of these analyzers has been reduced significantly. With the lesser turnaround time, doctors at several clinics are now able to accelerate the pace of diagnosis and treatment of their patients.
Market Growth Factors
Lack Of Precision And Versatility Of Analyzers
Despite a number of benefits of an automated visual field analyzer, there is a major drawback of this technology. Automated visual field analyzers are highly prone to making errors due to a number of factors. For example, the result of a test conducted with the automated field tester can be very easily hampered by incorrect placement of the head. Even a slight movement in the position of the patient's head can completely influence the result. Moreover, patients with severe glaucoma are very hard to be diagnosed accurately.
Type Outlook
On the basis of type, the Automated Visual Field Analyzer Market is bifurcated into Static and Kinetic. In 2021, the kinetic segment garnered a significant revenue share of the automated visual field analyzer market. The ability of kinetic visual field analyzers to capture moving stimuli and deliver precise results is one of its main advantages. Their main advantages include increased interaction between both the examiner and the patient, faster peripheral testing, and better spatial resolution.
Application Outlook
Based on Application, the Automated Visual Field Analyzer Market is segregated into Glaucoma, Age-related Macular Degeneration (AMD), Scotoma, and Others. In 2021, the glaucoma segment procured the highest revenue share of the automated visual field analyzer market. The optic nerve of the eye is damaged by glaucoma, which results in vision loss and blindness. Glaucoma is brought on by the usual fluid pressure in the eyes steadily raising.
End-User Outlook
By End-user, the Automated Visual Field Analyzer Market is segmented into Hospitals, Eye Clinics, and Others. In 2021, the hospitals segment witnessed the largest revenue share of the automated visual field analyzer market. The industry is being driven by both the increased prevalence of eye-related diseases and technological developments in automated visual field analyzers.
Regional Outlook
Region-Wise, the Automated Visual Field Analyzer Market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2021, North America held the biggest revenue share of the automated visual field analyzer market. This can be ascribed to the region's large number of market players and rise in ocular illness prevalence. The market for automated visual field analyzers is being driven by the high adoption of cutting-edge technology and benevolent reimbursement policies.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Topcon Corporation, Carl Zeiss AG, Metall Zug AG, Oculus Optikgerate GmbH, Kowa Company, Ltd., Heidelberg Engineering, Inc., Metrovision SAS, Optopol Technology Sp. z o.o., and MEDA Co., Ltd.
Strategies deployed in Automated Visual Field Analyzer Market
Partnerships, Collaborations and Agreements:
Dec-2019: Topcon partnered with Eastern Ophthalmic and Gold Coast Ophthalmic, two full-line authorized distributors. Under this partnership, Eastern Ophthalmic and Gold Coast Ophthalmic would commercialize Topcon's complete product portfolio, spanning from Topcon's industry-first fully automated OCT/fundus camera to its advanced digital and conventional refraction products and new data management software.
Product Launches and Product Expansions:
Apr-2022: Haag-Streit released the Eyestar 900, an Anterior Chamber Suit. Following this launch, the company aimed to fulfill the rising demand for enhanced results in refractive and cataract surgery. Moreover, the new swept-source OCT-based Eyestar 900 offers versatile tools for refractive and cataract surgery.
Aug-2019: Topcon unveiled the Maestro2, an automated OCT/Fundus camera. The new fully automated OCT Maestro2 can capture non-mydriatic high-resolution, true color fundus photography, OCTA, and OCT with a single click through its 360° rotating intuitive touchscreen and a space-saving design. Moreover, the new product also provides the Hood Report for the function/structure analysis of glaucoma.
Mar-2019: Zeiss introduced a new software upgrade to its Humphrey Field Analyzer. This product expansion aimed to establish 24-2C, a new testing protocol in response to the shift in customers' preference for testing and detection of macular injury within all stages of glaucoma. Moreover, the new software would also streamline and expedite visual field testing.
Dec-2018: Oculus rolled out the Smartfield perimeter. Through this launch, the company aimed to expand its compact visual field testing devices portfolio. The new device is specially optimized for central visual field functional impairment examinations. Furthermore, the new product also leverages an ultra-high luminance LCD display and its lower measurement durations make it compatible with standard screening methods.
Acquisitions and Mergers:
Jul-2020: Topcon Healthcare took over Elektron Eye Technology's Henson range of perimetry products. With this acquisition, the company aimed to leverage the prospect to strategically develop this sector of the product portfolio of the company. In addition, this Henson's product line would also complement the global strategy with the growing emphasis of Topcon on early disease detection and screening.
Market Segments covered in the Report:
By End-use
By Type
By Application
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures